Patient satisfaction with eletriptan in the acute treatment of migraine in primary care

International Journal of Clinical Practice

Volumn 61, Issue 10, 2007, Pages 1677-1685

  Nett, R B ^a   Tiseo, P J ^b   Almas, M ^b   Sikes, C R ^b  

^a Texas Headache Associates   (United States)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ELETRIPTAN;

ADULT; AGED; ANALGESIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; NAUSEA; PATIENT SATISFACTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; FAMILY PRACTICE; FEMALE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; PAIN MEASUREMENT; PATIENT SATISFACTION; PYRROLIDINES; QUALITY OF LIFE; QUESTIONNAIRES; SEROTONIN RECEPTOR AGONISTS; TREATMENT OUTCOME; TRYPTAMINES;

EID: 34548617697     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2007.01513.x     Document Type: Article

References (20)

1. Ferrari MD, Roon KI, Lipton RB, Goadsby PJ. Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet 2001 358 : 1668 75.
2. Helfand M, Peterson K. Drug Class Review on Triptans, 2006. http://egov.oregon.gov/DAS/OHPPR/HRC/docs/TRIPAN_EPC.pdf (accessed June 2006).
3. Oldman AD, Smith LA, McQuay HJ, Moore RA. Pharmacological treatments for acute migraine: quantitative systematic review. Pain 2002 97 : 247 57.
4. Albrecht G, Hoogstraten J. Satisfaction as a determinant of compliance. Community Dent Oral Epidemiol 1998 26 : 139 46.
5. Lipton RB, Stewart WF. Acute migraine therapy: Do doctors understand what patients with migraine want from therapy? Headache 1999 39 : S20 5.
6. Lipton RB, Scher AI, Steiner TJ et al. Patterns of health care utilization for migraine in England and in the United States. Neurology 2003 60 : 441 8.
7. Massiou H. Migraine medication attributes are important for patient compliance. Drugs Today (Barc) 2003 39 (Suppl. D 25 9.
8. Cutrer FM, Goadsby PJ, Ferrari MD et al. Priorities for triptan treatment attributes and the implications for selecting an oral triptan for acute migraine: a study of US primary care physicians (the TRIPSTAR Project). Clin Ther 2004 26 : 1533 45.
9. Ferrari MD, Goadsby PJ, Lipton RB et al. The use of multiattribute decision models in evaluating triptan treatment options in migraine. J Neurol 2005 252 : 1026 32.
10. Lipton RB, Cutrer FM, Goadsby PJ et al. How treatment priorities influence triptan preferences in clinical practice: perspectives of migraine sufferers, neurologists, and primary care physicians. Curr Med Res Opin 2005 21 : 413 24.
11. Headache Classification Committee of the International Headache Society. Classification and diagnosis criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988 8 : 1 96.
12. Lipton RB, Dodick D, Sadovsky R et al. A self-administered screener for migraine in primary care: the ID Migraine validation study. Neurology 2003 61 : 375 82.
13. Davies GM, Santanello N, Lipton R. Determinants of patient satisfaction with migraine therapy. Cephalalgia 2000 20 : 554 60.
14. Santanello NC, Hartmaier SL, Epstein RS, Silberstein SD. Validation of a new quality of life questionnaire for acute migraine headache. Headache 1995 35 : 330 7.
15. Hartmaier SL, Santanello NC, Epstein RS, Silberstein SD. Development of a brief 24-hour migraine-specific quality of life questionnaire. Headache 1995 35 : 320 9.
16. Pathak DS, Chisolm DJ, Weis KA. Functional Assessment in Migraine (FAIM) questionnaire: development of an instrument based upon the WHO's International Classification of Functioning, Disability, and Health. Value Health 2005 8 : 591 600.
17. International Conference on Harmonization. Guidance for Industry. E6 Good Clinical Practice: Consolidated Guidance, 1996. http://www.fda.gov/cder/ guidance/959fnl.pdf (accessed June 2006).
18. Lipton RB, Hamelsky SW, Dayno JM. What do patients with migraine want from acute migraine treatment? Headache 2002 42 : S3 9.
19. Färkkilä M, Olesen J, Dahlöf C et al. Eletriptan for the treatment of migraine in patients with previous poor response or tolerance to oral sumatriptan. Cephalalgia 2003 23 : 463 71.
20. Goldstein J, Tiseo PJ, Albert KS, Li C, Sykes CR. Eletriptan in migraine patients reporting unsatisfactory response to rizatriptan. Headache 2006 46 : 1142 50.